Nanocare

About Nanocare

Nanocare is a development-stage biotechnology company focused on transforming oncology with innovative, targeted drug complexes designed to attack cancer cells while minimizing harm to patients. Their approach centers on targeting a key protein in cancer cells, cytochrome-c, to modulate apoptosis and disrupt mitochondrial dynamics, aiming to halt growth and prevent metastasis while enhancing the immune response. The company emphasizes international collaboration and aims to develop disease-modifying cancer therapies with a focus on dignity and patient safety. While based on cutting-edge science, Nanocare positions itself as a research-driven biotech entity dedicated to advancing cancer treatment.